Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame	Description
Primary	plasma Metanephrines	Perioperative
Secondary	Intraoperative blood pressure	Perioperative
Secondary	Intraoperative heart rate	Perioperative
Secondary	Intraoperative dosage of vasoactive agents	Perioperative
Secondary	Intraoperative fluid infusion volume	Perioperative
Secondary	Postoperative ICU admission rate	Perioperative
Secondary	Incidence of perioperative cardiovascular and cerebrovascular complications and mortality	Perioperative
Secondary	Postoperative use of vasoactive agents	Perioperative
Secondary	Postoperative blood MNs level	Perioperative
Secondary	Catecholamine levels in surgically resected tumor tissue	Perioperative	The concentrations of catecholamines (epinephrine, norepinephrine, dopamine) within surgically resected pheochromocytoma/paraganglioma tumor tissue will be measured and compared between study groups.
Secondary	Safety evaluation of belzutifan	After patient discharge

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07907341/registered